Katie Capps from GTMRx Institute was a guest on our podcast, Precision Insights, and gave listeners an overview on what comprehensive medication management (CMM) is, and how pharmacogenetics can become part of that process. We’ve taken some of the highlights of this episode and put...
All TreatGx users now have access to the updated treatment algorithms for Hypertension and Migraine. As always, these updates include the TreatGx standard of providing personalized dosing based on pharmacogenetics, kidney function, liver function, and drug interactions. General updates: a scope message has now been added...
At the time of recording, Colleen Keenan was a consultant with Advisory Board’s Clinical Innovators Council, a membership group for researchers designed to help suppliers strengthen their relationships with integrated delivery networks and their providers. Colleen had been with Advisory Board for over four years...
GenXys, a health tech company focused on pharmacogenetic enhanced prescribing automation software, is pleased to announce that it has closed an oversubscribed seed round at $3 million. Led by Green Shield Canada, (GSC), with key investors including TELUS Ventures, Esplanade Ventures, Nimbus Synergies, and the...
The fantastic Sara Rogers of the American Society of Pharmacovigilance (ASP) and the Pharmacogenetics Access and Reimbursement Coalition (PARC) joined us in an episode of Precision Insights to discuss ASP, PARC, and the STRIPE Collaborative Community, which aims to accelerate the development of personalized medicine...
We've got an exciting product release to share with you. This enterprise release of our software extends the capability, interoperability, security, and performance of the most robust and most performant pharmacogenetic (PGx) supported precision prescribing platform on the market. Falling into the wider category of...
We've got an exciting product release to share with you. This enterprise release of our software extends the capability, interoperability, security, and performance of the most robust and most performant pharmacogenetic (PGx) supported precision prescribing platform on the market. Falling into the wider category of...
We are pleased to announce an update to our Schizophrenia treatment algorithm. All TreatGx users now have access to the updated algorithm which includes many exciting enhancements that will help health care providers select the safest and most effective medications for their patients with schizophrenia. One...
When Melissa Badowski came on our podcast, Precision Insights, to talk about her experiences using telehealth, we were very excited to hear about how she uses it to deliver comprehensive medication management, and her tips for delivering telehealth more effectively. ...
All TreatGx users now have access to the updated treatment algorithm for Chronic Pain - Fibromyalgia. This update incorporates information from the most recent clinical guidelines and literature, including the American College of Physicians[1], the European League Against Rheumatism[2], and the Cochrane Database of Systematic Reviews[3-6]. The algorithm has been simplified for ease of use...
